ClinConnect ClinConnect Logo
Search / Trial NCT05817474

Efficacy of Local Infiltration of Tranexamic Acid and Lidocaine in Tonsillar Bed on Postoperative Bleeding and Pain During Tonsillectomy Surgery: Prospective, Randomized, Control Study

Launched by MOHAMED · Apr 5, 2023

Trial Information

Current as of August 02, 2025

Completed

Keywords

Tonsillectomy Lidocaine

ClinConnect Summary

The control of postoperative pain in children after tonsillectomy is a crucial issue. After a tonsillectomy, it is crucial to receive enough postoperative analgesia since discomfort limits swallowing, increases the risk of dehydration, infection, and subsequent bleeding, and can impede a quick recovery and painless convalescence. Immediately following surgery and during the first 24th hours, this pain is at its most intense (1).

The main reason for reoperation and mortality in children who have had tonsillectomy is post-tonsillectomy hemorrhage (PTH). These two categories of PTH as primary...

Gender

ALL

Eligibility criteria

  • Inclusion criteria
  • 1. Male or female child between 4 and 12 years old
  • 2. ASA one and two, planned for an elective tonsillectomy
  • 3. Patients having 4 or more episodes of tonsillitis in the last year, 5 or more episodes in the previous two years, or 7 episodes in the previous three years.
  • Exclusion criteria
  • 1-Children with diabetes mellitus, problems of the heart, kidneys, or liver 4-Obstructive sleep apnea syndrome 5-blood disorders, or a propensity to hemorrhage 6-patients suspected of an allergy to the drug being administered, and those undergoing concurrent surgery such as an adenoidectomy or tongue tie.

About Mohamed

Mohamed is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodologies and ethical standards, Mohamed collaborates with leading researchers and institutions to conduct high-quality clinical studies across various therapeutic areas. The organization prioritizes patient safety and data integrity, ensuring that each trial contributes valuable insights to the medical community. Through its strategic partnerships and commitment to excellence, Mohamed aims to accelerate the development of groundbreaking treatments that address unmet medical needs.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Trial Officials

abdalla mohamed abdalla, MD

Principal Investigator

AZHAR

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials